Total astragalus saponins attenuate primary sclerosing cholangitis in mice by upregulation of TGR5
Phytotherapy Research · 2024
DOI: 10.1002/ptr.8297 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2024. Verfasst von Qun Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Liver and Kidney Diseases of Ministry of Education, Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Institute of …. Hauptthemen laut MEDLINE: Astragalus Plant, Cholangitis, Sclerosing, Receptors, G-Protein-Coupled, Saponins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Shanghai Science and Technology Committee Rising-Star Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Total astragalus saponins (TAS) are the main active components of astragali radix , and have potent anti‐hepatic fibrosis effect. However, the therapeutic efficacy of TAS and their potential mechanisms in the treatment of primary sclerosing cholangitis (PSC) remain unclear. In this study, two mouse models of PSC, including 3,5‐Diethoxycarbonyl‐1,4‐Dihydro‐2,4,6‐Collidine (DDC)‐induced PSC and Mdr2 −/− spontaneous PSC, and the Tgr5 −/− mice were used to investigate the therapeutic effect and mechanisms of TAS. Treatment with TAS, particularly with a dose of 56 mg/kg, significantly ameliorated the PSC‐related liver injury, cholestasis, collagen deposition, ductular reaction (DR), and fibrosis in the DDC‐induced and Mdr2 −/− spontaneous PSC mice. Furthermore, treatment with TAS significantly mitigated the PSC‐related inflammatory responses in vivo and HIBEpiC cells by inhibiting the expression of TNF‐α, IL‐6, and IL‐1β. Mechanistically, treatment with TAS rescued the PSC‐decreased hepatic TGR5 expression to attenuate the NF‐κB p65 phosphorylation. Notably, the therapeutic efficacy of TAS on PSC in DDC‐induced mice was abrogated in Tgr5 −/− mice, suggesting the anti‐PSC effect of TAS may depend on enhancing TGR5 expression. In conclusion, TAS ameliorated DR, inflammation and liver fibrosis in both models of PSC mice by rescuing TGR5 expression. Our findings may aid in the design of new therapeutic strategies for the treatment of PSC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Liver and Kidney Diseases of Ministry of Education, Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of…
- Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai Frontiers Science Center of TCM Chemical Biology, Shanghai, China.
ORCID-Profile: Jiamei Chen
Förderung
- Shanghai Science and Technology Committee Rising-Star Program
- National Natural Science Foundation of China
Zitieren
APA
Zhou, Q., Gao, S., Yu, X., Zhang, L., Zhang, Z., Fu, Y., Liu, W., Mu, Y., Zhang, H., Liu, P., & Chen, J. (2024). Total astragalus saponins attenuate primary sclerosing cholangitis in mice by upregulation of TGR5. Phytotherapy Research. https://doi.org/10.1002/ptr.8297
Vancouver
Zhou Q, Gao S, Yu X, Zhang L, Zhang Z, Fu Y, et al. Total astragalus saponins attenuate primary sclerosing cholangitis in mice by upregulation of TGR5. Phytotherapy Research. 2024. doi:10.1002/ptr.8297
BibTeX
@article{Zhou2024,
author = {Zhou, Qun and Gao, Siqi and Yu, Xiaohan and Zhang, Linzhang and Zhang, Zheng and Fu, Yadong and Liu, Wei and Mu, Yongping and Zhang, Hua and Liu, Ping and Chen, Jiamei},
title = {Total astragalus saponins attenuate primary sclerosing cholangitis in mice by upregulation of TGR5},
journal = {Phytotherapy Research},
year = {2024},
doi = {10.1002/ptr.8297}
}
EUVIMED